Corvus Pharmaceuticals
CRVS
CRVS
42 hedge funds and large institutions have $18.1M invested in Corvus Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less call options, than puts
Call options by funds: $23K | Put options by funds: $31K
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Holders
42
Holding in Top 10
1
Calls
$23K
Puts
$31K
Top Buyers
| 1 | +$466K | |
| 2 | +$28.3K | |
| 3 | +$17K | |
| 4 |
VF
Virtu Financial
New York
|
+$16K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.03K |
Top Sellers
| 1 | -$311K | |
| 2 | -$278K | |
| 3 | -$187K | |
| 4 |
Two Sigma Investments
New York
|
-$126K |
| 5 |
TI
Telemetry Investments
New York
|
-$112K |